HealthEquity, Inc. filed its Form 10-Q for the quarterly period ended July 31, 2026, reporting net income of $65.6 million for the three months ended July 31, 2026, and $135.1 million for the six months ended July 31, 2026.

Key Highlights

  • Total revenue (Q2): $350.7 million for the three months ended July 31, 2026, up from $325.8 million in the same period of the prior year, according to the filing.
  • Net income (Q2): $65.6 million for the three months ended July 31, 2026, compared to $59.9 million in the prior-year quarter.
  • Diluted EPS (Q2): $0.78 per share for the three months ended July 31, 2026, versus $0.68 in the prior-year quarter.
  • Six-month total revenue: $705.4 million for the six months ended July 31, 2026, compared to $656.7 million in the prior-year period.
  • Share count: As of August 20, 2026, the filing disclosed 82,715,296 shares of common stock outstanding.
  • Common shares repurchased: The company reported $231.1 million in total repurchases charged against additional paid-in capital and accumulated earnings for the six months ended July 31, 2026 (combining $62.8 million and $168.4 million, respectively).
  • Total assets: $3.271 billion as of July 31, 2026, compared to $3.380 billion as of January 31, 2026.

HealthEquity Q2 Fiscal 2027: Revenue Growth and Earnings Detail

According to the 10-Q filed with the SEC for the quarterly period ended July 31, 2026, HealthEquity, Inc. (NASDAQ:HQY) reported total revenue of $350.7 million for the three months ended July 31, 2026. The filing breaks this into three streams: service revenue of $124.4 million, custodial revenue of $175.9 million, and interchange revenue of $50.4 million. For the comparable prior-year quarter, those figures were $117.9 million, $159.9 million, and $48.1 million, respectively. Gross profit for the second quarter was $258.0 million, up from $232.6 million in the prior-year period, the filing disclosed.

For the six months ended July 31, 2026, the registrant reported total revenue of $705.4 million and net income of $135.1 million, compared to $656.7 million in revenue and $113.8 million in net income for the six months ended July 31, 2025. Income from operations reached $201.6 million for the six-month period, versus $172.7 million in the prior-year period, according to the filing. Interest expense declined to $25.2 million for the six months ended July 31, 2026, from $29.8 million in the same prior-year period.

The condensed consolidated balance sheet as of July 31, 2026, showed total assets of $3.271 billion, with goodwill of $1.648 billion and intangible assets, net, of $1.048 billion. Long-term debt, net of issuance costs, stood at $931.1 million. Total stockholders' equity was $1.990 billion as of July 31, 2026, compared to $2.107 billion as of January 31, 2026. The filing noted accumulated other comprehensive loss of $69.1 million as of July 31, 2026, reflecting net unrealized losses on cash flow hedges of $63.2 million for the six-month period, net of income tax benefit of $20.6 million.

What Was Disclosed

HealthEquity's 10-Q for the period ended July 31, 2026, disclosed quarterly and six-month revenue, net income, earnings per share, balance sheet data, and stockholders' equity activity, including share repurchases and cash flow hedge losses recorded in other comprehensive loss.